UNC Lineberger News

University Cancer Research Fund Grant Teams Lineberger Faculty with Renaissance Computing Institute to Battle Skin Cancer

University Cancer Research Fund Grant Teams Lineberger Faculty with Renaissance Computing Institute to Battle Skin Cancer

CHAPEL HILL, NC - A new collaboration between melanoma researchers in the School of Medicine at the University of North Carolina at Chapel Hill, the Renaissance Computing Institute (RENCI), and researchers from the departments of computer science, epidemiology, biostatistics, and statistics and operations research at UNC Chapel Hill aims to use image analysis techniques to aid doctors in the fight against melanoma, the most serious form of skin cancer.

University Cancer Research Fund Grant Teams Lineberger Faculty with Renaissance Computing Institute to Battle Skin Cancer - Read More…

UCRF Spurs Large Private Gift for Cancer Research

CHAPEL HILL - Fred Eshelman, chief executive officer and founder of Wilmington-based PPD Inc., has pledged $9 million to support cancer research at the School of Pharmacy at the University of North Carolina at Chapel Hill.

UCRF Spurs Large Private Gift for Cancer Research - Read More…

UNC-Chapel Hill, ECU Team up on Cancer Care, Research

UNC-Chapel Hill, ECU Team up on Cancer Care, Research

CHAPEL HILL - The University of North Carolina’s two medical schools and their cancer centers have signed a memorandum of understanding that creates a partnership to advance cancer research and bring leading-edge treatment to North Carolinians.

UNC-Chapel Hill, ECU Team up on Cancer Care, Research - Read More…

University Cancer Research Fund panel sets priorities, adds national experts

CHAPEL HILL – The governance committee of the University Cancer Research Fund has established first-year spending priorities for the state’s initial $25 million investment at the University of North Carolina at Chapel Hill.

University Cancer Research Fund panel sets priorities, adds national experts - Read More…

Former GlaxoSmithKline Executive to Lead UNC Drug Discovery Center

Former GlaxoSmithKline Executive to Lead UNC Drug Discovery Center

Stephen Frye, PhD, former worldwide head of discovery medicinal chemistry at GlaxoSmithKline, will lead the new Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill.

Former GlaxoSmithKline Executive to Lead UNC Drug Discovery Center - Read More…

"Waging War on Cancer"

Winston-Salem Journal Editorial, August 8, 2007

"Waging War on Cancer" - Read More…